Göran Forsberg
Chief Executive Officer at CANTARGIA AB
Net worth: 92 523 $ as of 30/04/2024
Network origin in Göran Forsberg first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Göran Forsberg via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELECTROLUX AB | Electronics/Appliances | Corporate Officer/Principal | |
| COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Director of Finance/CFO | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Stockholm | College/University | Undergraduate Degree Graduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| University of Lund | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree | |
| ENSIMAG | College/University | Graduate Degree | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Extenda AB
 Extenda AB Information Technology ServicesTechnology Services Extenda AB develops point-of-sale technology (POS) solutions. Its product suite include transaction engine, selfscan, mobile POS, and self checkout. The firm also offers support, service and maintenance, and catalogue services. The company was founded by Peter Carlman in 1982 and is headquartered in Stockholm, Sweden. | Information Technology Services | Director of Finance/CFO | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact | |
| QLUCORE AB | Packaged Software | Chairman Founder | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NOBINA AB (PUBL) | Other Transportation | Chairman Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| The International Venture Club | Corporate Officer/Principal | ||
OnTarget Chemistry AB
 OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The private company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
| DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Sunstone LSV Management A/S | Director/Board Member | ||
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
| Oncopeptides Incentive AB | Director/Board Member | ||
| Sciencecap Stockholm AB | Director/Board Member | ||
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Parsimoneous Holding ApS
 Parsimoneous Holding ApS Financial ConglomeratesFinance Parsimoneous Holding ApS functions as an investment holding Danish company. The private company is based in Gentofte, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The private company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lisa Martin-Löf Konsultbyrå AB | Director/Board Member | ||
| Synartro AB | Chairman | ||
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director of Finance/CFO | |
| OT Pharmaceuticals AB | Chief Executive Officer | ||
| COEGIN PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
| Neodos AB | Director/Board Member |
Statistics
International
| Sweden | 41 |
| Denmark | 6 |
| France | 2 |
| Germany | 2 |
| United States | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Finance | 5 |
| Technology Services | 4 |
| Consumer Durables | 2 |
Operational
| Director/Board Member | 157 |
| Corporate Officer/Principal | 60 |
| Chairman | 47 |
| Independent Dir/Board Member | 42 |
| Chief Executive Officer | 32 |
Most connected contacts
- Stock Market
- Insiders
- Göran Forsberg
- Company connections
